CDIOW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CTCXW, CELUW, CEROW, and CINGW
Should you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.
Cardio Diagnostics vs.
Cardio Diagnostics (NASDAQ:CDIOW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, community ranking, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.
Cardio Diagnostics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
In the previous week, 180 Life Sciences had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Cardio Diagnostics. 180 Life Sciences' average media sentiment score of 1.38 beat Cardio Diagnostics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Summary
180 Life Sciences beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.
Get Cardio Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CDIOW vs. The Competition
Cardio Diagnostics Competitors List
Related Companies and Tools
This page (NASDAQ:CDIOW) was last updated on 2/22/2025 by MarketBeat.com Staff
